| Li, Weiming |
CMML1-2, NCT06647862: IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia |
|
|
| Recruiting | 3 | 170 | RoW | IMM01, Timdarpacept, Azacitidine, Placebo | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Chronic Myelomonocytic Leukemia | 10/26 | 10/29 | | |
NCT04684472: Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies |
|
|
| Recruiting | 1 | 18 | RoW | Modified anti-CD19 CAR T cells | Liqun Zou | Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Leukemia | 01/23 | 01/24 | | |
NCT06604572: TAPP and Open Repair for Recurrent Inguinal Hernia |
|
|
| Recruiting | N/A | 70 | RoW | Transabdominal preperitoneal approach, Open tension-free hernia repair | The Second Affiliated Hospital of Kunming Medical University | Recurrent Inguinal Hernia | 10/24 | 10/25 | | |
NCT06006026: The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery |
|
|
| Recruiting | N/A | 9 | RoW | Ropivacaine Hydrochloride 10 MG/ML [Naropin] | West China Hospital | Colorectal Cancer | 05/24 | 05/24 | | |
NCT05920980: Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery |
|
|
| Enrolling by invitation | N/A | 276 | RoW | lidocaine, Placebo, placebo group | West China Hospital | Colorectal Cancer | 06/24 | 06/24 | | |
| Cai, Hongbing |
NCT05622890: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer |
|
|
| Recruiting | 3 | 35 | RoW | Mirvetuximab Soravtansine, IMGN853, MIRV | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | 04/23 | 12/23 | | |
